Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4885754_AE85754_0